

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.60810820 |
| 2 | actin-myosin filament sliding (GO:0033275) | 6.27761760 |
| 3 | muscle filament sliding (GO:0030049) | 6.27761760 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.32844500 |
| 5 | skeletal muscle contraction (GO:0003009) | 5.18025859 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.16896936 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.12084306 |
| 8 | actin-mediated cell contraction (GO:0070252) | 5.08853177 |
| 9 | locomotory exploration behavior (GO:0035641) | 4.98027571 |
| 10 | synaptic vesicle maturation (GO:0016188) | 4.95343666 |
| 11 | regulation of skeletal muscle contraction (GO:0014819) | 4.94413963 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 4.87686881 |
| 13 | regulation of cell communication by electrical coupling (GO:0010649) | 4.70282226 |
| 14 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.63091740 |
| 15 | neuronal action potential propagation (GO:0019227) | 4.62853449 |
| 16 | striated muscle contraction (GO:0006941) | 4.52677564 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.48733784 |
| 18 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.47137396 |
| 19 | vocalization behavior (GO:0071625) | 4.45764654 |
| 20 | synaptic vesicle exocytosis (GO:0016079) | 4.41986379 |
| 21 | transmission of nerve impulse (GO:0019226) | 4.29170328 |
| 22 | creatine metabolic process (GO:0006600) | 4.24731660 |
| 23 | axon ensheathment in central nervous system (GO:0032291) | 4.23759417 |
| 24 | central nervous system myelination (GO:0022010) | 4.23759417 |
| 25 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.21637955 |
| 26 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.21420033 |
| 27 | regulation of synapse structural plasticity (GO:0051823) | 4.19354726 |
| 28 | myofibril assembly (GO:0030239) | 4.15979755 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.11359988 |
| 30 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.11338644 |
| 31 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.08730399 |
| 32 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.08145081 |
| 33 | neuron cell-cell adhesion (GO:0007158) | 4.06419161 |
| 34 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 4.05399208 |
| 35 | neuromuscular synaptic transmission (GO:0007274) | 4.04574999 |
| 36 | neuronal ion channel clustering (GO:0045161) | 4.04309881 |
| 37 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.02339868 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.95951536 |
| 39 | positive regulation of synapse maturation (GO:0090129) | 3.95871127 |
| 40 | protein localization to synapse (GO:0035418) | 3.92983808 |
| 41 | glutamate secretion (GO:0014047) | 3.91766155 |
| 42 | sodium ion export (GO:0071436) | 3.88612529 |
| 43 | skeletal muscle fiber development (GO:0048741) | 3.87642149 |
| 44 | synaptic transmission, glutamatergic (GO:0035249) | 3.86590993 |
| 45 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.86576919 |
| 46 | neuron-neuron synaptic transmission (GO:0007270) | 3.83257597 |
| 47 | actin filament-based movement (GO:0030048) | 3.82350054 |
| 48 | cardiac muscle contraction (GO:0060048) | 3.81556482 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.79804939 |
| 50 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.76941021 |
| 51 | response to inactivity (GO:0014854) | 3.76212466 |
| 52 | positive regulation of membrane potential (GO:0045838) | 3.74438395 |
| 53 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.69664181 |
| 54 | glutamate receptor signaling pathway (GO:0007215) | 3.67689306 |
| 55 | potassium ion import (GO:0010107) | 3.65168161 |
| 56 | exploration behavior (GO:0035640) | 3.63720669 |
| 57 | gamma-aminobutyric acid transport (GO:0015812) | 3.63303187 |
| 58 | plasma membrane repair (GO:0001778) | 3.63185402 |
| 59 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.60861642 |
| 60 | synaptic transmission, dopaminergic (GO:0001963) | 3.60433143 |
| 61 | regulation of synaptic vesicle transport (GO:1902803) | 3.60222530 |
| 62 | prepulse inhibition (GO:0060134) | 3.59198649 |
| 63 | neurotransmitter secretion (GO:0007269) | 3.59194858 |
| 64 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.56306042 |
| 65 | presynaptic membrane assembly (GO:0097105) | 3.56262244 |
| 66 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.54710116 |
| 67 | regulation of actin filament-based movement (GO:1903115) | 3.52825094 |
| 68 | myotube cell development (GO:0014904) | 3.52491512 |
| 69 | long-term memory (GO:0007616) | 3.52122352 |
| 70 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.51221070 |
| 71 | sarcomere organization (GO:0045214) | 3.51150490 |
| 72 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.49367250 |
| 73 | muscle contraction (GO:0006936) | 3.45944720 |
| 74 | adult walking behavior (GO:0007628) | 3.45241245 |
| 75 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.43711696 |
| 76 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.43711696 |
| 77 | presynaptic membrane organization (GO:0097090) | 3.43432250 |
| 78 | behavioral response to cocaine (GO:0048148) | 3.40898305 |
| 79 | L-amino acid import (GO:0043092) | 3.36460085 |
| 80 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.36025069 |
| 81 | regulation of postsynaptic membrane potential (GO:0060078) | 3.35745121 |
| 82 | auditory behavior (GO:0031223) | 3.35159361 |
| 83 | cardiac muscle hypertrophy (GO:0003300) | 3.35009156 |
| 84 | neuromuscular process controlling balance (GO:0050885) | 3.34766386 |
| 85 | response to muscle activity (GO:0014850) | 3.32902072 |
| 86 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.31779766 |
| 87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.31640065 |
| 88 | regulation of synapse maturation (GO:0090128) | 3.30959810 |
| 89 | striatum development (GO:0021756) | 3.29914415 |
| 90 | regulation of synaptic plasticity (GO:0048167) | 3.29709356 |
| 91 | myelination (GO:0042552) | 3.29467801 |
| 92 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.29363157 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.25726754 |
| 94 | ensheathment of neurons (GO:0007272) | 3.25151116 |
| 95 | axon ensheathment (GO:0008366) | 3.25151116 |
| 96 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.24545483 |
| 97 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.23980355 |
| 98 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.23163393 |
| 99 | cardiac myofibril assembly (GO:0055003) | 3.23111200 |
| 100 | glycine transport (GO:0015816) | 3.21225343 |
| 101 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.20628489 |
| 102 | regulation of dendritic spine development (GO:0060998) | 3.20559103 |
| 103 | negative regulation of neurotransmitter transport (GO:0051589) | 3.20311081 |
| 104 | regulation of membrane repolarization (GO:0060306) | 3.20164206 |
| 105 | postsynaptic membrane organization (GO:0001941) | 3.19693420 |
| 106 | regulation of glutamate secretion (GO:0014048) | 3.19074888 |
| 107 | membrane hyperpolarization (GO:0060081) | 3.18499278 |
| 108 | layer formation in cerebral cortex (GO:0021819) | 3.18429650 |
| 109 | striated muscle hypertrophy (GO:0014897) | 3.17746332 |
| 110 | regulation of sodium ion transmembrane transporter activity (GO:2000649) | 3.16457211 |
| 111 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.16344418 |
| 112 | neuromuscular process controlling posture (GO:0050884) | 3.14321560 |
| 113 | muscle system process (GO:0003012) | 3.12185449 |
| 114 | long-term synaptic potentiation (GO:0060291) | 3.11992065 |
| 115 | potassium ion homeostasis (GO:0055075) | 3.09957108 |
| 116 | skeletal muscle adaptation (GO:0043501) | 3.09669520 |
| 117 | positive regulation of neurotransmitter transport (GO:0051590) | 3.08274473 |
| 118 | neuron recognition (GO:0008038) | 3.07962821 |
| 119 | response to auditory stimulus (GO:0010996) | 3.07811304 |
| 120 | cell communication by electrical coupling (GO:0010644) | 3.07561703 |
| 121 | regulation of sodium ion transmembrane transport (GO:1902305) | 3.07127449 |
| 122 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.05566985 |
| 123 | cerebellar granule cell differentiation (GO:0021707) | 3.04591161 |
| 124 | glycogen catabolic process (GO:0005980) | 3.04231512 |
| 125 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.04156839 |
| 126 | neurotransmitter transport (GO:0006836) | 3.03517919 |
| 127 | regulation of neurotransmitter secretion (GO:0046928) | 3.00468159 |
| 128 | striated muscle adaptation (GO:0014888) | 2.98096404 |
| 129 | mating behavior (GO:0007617) | 2.97876522 |
| 130 | proline transport (GO:0015824) | 2.97108047 |
| 131 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.97060841 |
| 132 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.97060841 |
| 133 | detection of calcium ion (GO:0005513) | 2.96789647 |
| 134 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.96786204 |
| 135 | membrane depolarization (GO:0051899) | 2.96698056 |
| 136 | cardiac muscle adaptation (GO:0014887) | 2.94959491 |
| 137 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.94959491 |
| 138 | muscle hypertrophy in response to stress (GO:0003299) | 2.94959491 |
| 139 | muscle fiber development (GO:0048747) | 2.93408680 |
| 140 | regulation of neurotransmitter transport (GO:0051588) | 2.93399111 |
| 141 | learning (GO:0007612) | 2.93316458 |
| 142 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.93159727 |
| 143 | regulation of vesicle fusion (GO:0031338) | 2.92239619 |
| 144 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.91286625 |
| 145 | cyclic nucleotide catabolic process (GO:0009214) | 2.89721171 |
| 146 | dendritic spine organization (GO:0097061) | 2.89299109 |
| 147 | dendrite morphogenesis (GO:0048813) | 2.88780819 |
| 148 | positive regulation of dendritic spine development (GO:0060999) | 2.88722848 |
| 149 | regulation of neurotransmitter levels (GO:0001505) | 2.87779560 |
| 150 | response to amphetamine (GO:0001975) | 2.86327745 |
| 151 | actomyosin structure organization (GO:0031032) | 2.86278491 |
| 152 | relaxation of muscle (GO:0090075) | 2.85054808 |
| 153 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.84392046 |
| 154 | neurotransmitter uptake (GO:0001504) | 2.84029013 |
| 155 | regulation of female receptivity (GO:0045924) | 2.82877763 |
| 156 | vesicle transport along microtubule (GO:0047496) | 2.82451799 |
| 157 | membrane depolarization during action potential (GO:0086010) | 2.82238228 |
| 158 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.81982461 |
| 159 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.81750489 |
| 160 | cellular potassium ion homeostasis (GO:0030007) | 2.80323238 |
| 161 | negative regulation of amino acid transport (GO:0051956) | 2.80022651 |
| 162 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.79402750 |
| 163 | visual learning (GO:0008542) | 2.79176337 |
| 164 | activation of protein kinase A activity (GO:0034199) | 2.78374312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.94631357 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54292474 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06272557 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.01887299 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.95238861 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.84334926 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.70911637 |
| 8 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.70911637 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64705865 |
| 10 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56151690 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.53673707 |
| 12 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.49373222 |
| 13 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.49242576 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48329398 |
| 15 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48099843 |
| 16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.42961934 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33456181 |
| 18 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.28726745 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.27569837 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16090451 |
| 21 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.12407214 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07312357 |
| 23 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01215447 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.96577701 |
| 25 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86755053 |
| 26 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.83584798 |
| 27 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.77822388 |
| 28 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.72365717 |
| 29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.67834838 |
| 30 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62744875 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.60246449 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.53580038 |
| 33 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.52689761 |
| 34 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.51733564 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.51278338 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.51039000 |
| 37 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.49502335 |
| 38 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.49295885 |
| 39 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44500215 |
| 40 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.40302776 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38586656 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.37954514 |
| 43 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37808879 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.34143113 |
| 45 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.33871291 |
| 46 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.32407688 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.32355028 |
| 48 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.30678053 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28746312 |
| 50 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.28545734 |
| 51 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.26228854 |
| 52 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24919076 |
| 53 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23598654 |
| 54 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.23428577 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22982309 |
| 56 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.22567808 |
| 57 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21333938 |
| 58 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21021945 |
| 59 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20354264 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19033430 |
| 61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18970666 |
| 62 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18029347 |
| 63 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.18003139 |
| 64 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16103578 |
| 65 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.15789672 |
| 66 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.15373839 |
| 67 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12808431 |
| 68 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.12608171 |
| 69 | * AR_19668381_ChIP-Seq_PC3_Human | 1.09970896 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09580739 |
| 71 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.07262698 |
| 72 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.07222603 |
| 73 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06116540 |
| 74 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05160874 |
| 75 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.04958309 |
| 76 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04932237 |
| 77 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04932237 |
| 78 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04553438 |
| 79 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.04189548 |
| 80 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00693999 |
| 81 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.00398548 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99780777 |
| 83 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99584866 |
| 84 | AR_25329375_ChIP-Seq_VCAP_Human | 0.98801355 |
| 85 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98381232 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.97062242 |
| 87 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96792387 |
| 88 | KDM2B_26808549_Chip-Seq_K562_Human | 0.96502387 |
| 89 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.95968766 |
| 90 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.95925065 |
| 91 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.95591222 |
| 92 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.94922957 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.94059522 |
| 94 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93573830 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93252561 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93152993 |
| 97 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.91814542 |
| 98 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91741720 |
| 99 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91640669 |
| 100 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91564442 |
| 101 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90930271 |
| 102 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90398211 |
| 103 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.90261389 |
| 104 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90108119 |
| 105 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89493480 |
| 106 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88885567 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.88276458 |
| 108 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86680489 |
| 109 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.86482485 |
| 110 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86439895 |
| 111 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.86406597 |
| 112 | RXR_22108803_ChIP-Seq_LS180_Human | 0.85458951 |
| 113 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.85288075 |
| 114 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.84810259 |
| 115 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.84216550 |
| 116 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.81633665 |
| 117 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.81070873 |
| 118 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79340573 |
| 119 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.77967795 |
| 120 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.77681079 |
| 121 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.77463695 |
| 122 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.76010681 |
| 123 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.75535014 |
| 124 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.73721009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.01889218 |
| 2 | MP0003880_abnormal_central_pattern | 4.90643607 |
| 3 | MP0002822_catalepsy | 4.75430162 |
| 4 | MP0004270_analgesia | 3.86748056 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.83147257 |
| 6 | MP0009745_abnormal_behavioral_response | 3.41277098 |
| 7 | MP0002064_seizures | 3.19553978 |
| 8 | MP0009046_muscle_twitch | 3.05946266 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.01223520 |
| 10 | MP0002272_abnormal_nervous_system | 2.86662301 |
| 11 | MP0001486_abnormal_startle_reflex | 2.86155812 |
| 12 | MP0002572_abnormal_emotion/affect_behav | 2.61085817 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.51243891 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.38654262 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.37103161 |
| 16 | MP0001968_abnormal_touch/_nociception | 2.36259130 |
| 17 | MP0001529_abnormal_vocalization | 2.34056163 |
| 18 | MP0000920_abnormal_myelination | 2.29134678 |
| 19 | MP0000759_abnormal_skeletal_muscle | 2.19548249 |
| 20 | MP0004087_abnormal_muscle_fiber | 2.12673432 |
| 21 | MP0001501_abnormal_sleep_pattern | 2.10325439 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.07567292 |
| 23 | MP0005369_muscle_phenotype | 2.00799830 |
| 24 | MP0003329_amyloid_beta_deposits | 1.93277730 |
| 25 | MP0002269_muscular_atrophy | 1.92513154 |
| 26 | MP0004885_abnormal_endolymph | 1.89375786 |
| 27 | MP0008569_lethality_at_weaning | 1.89149054 |
| 28 | MP0004924_abnormal_behavior | 1.88316672 |
| 29 | MP0005386_behavior/neurological_phenoty | 1.88316672 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.87114132 |
| 31 | MP0003690_abnormal_glial_cell | 1.83903917 |
| 32 | MP0004233_abnormal_muscle_weight | 1.83517373 |
| 33 | MP0001970_abnormal_pain_threshold | 1.78776311 |
| 34 | MP0002067_abnormal_sensory_capabilities | 1.78713633 |
| 35 | MP0001905_abnormal_dopamine_level | 1.77058914 |
| 36 | MP0002733_abnormal_thermal_nociception | 1.75694473 |
| 37 | MP0002736_abnormal_nociception_after | 1.72201211 |
| 38 | MP0000778_abnormal_nervous_system | 1.69678858 |
| 39 | MP0000750_abnormal_muscle_regeneration | 1.67557436 |
| 40 | MP0004084_abnormal_cardiac_muscle | 1.67308664 |
| 41 | MP0005646_abnormal_pituitary_gland | 1.66112798 |
| 42 | MP0002735_abnormal_chemical_nociception | 1.65979994 |
| 43 | MP0000955_abnormal_spinal_cord | 1.57588104 |
| 44 | MP0004142_abnormal_muscle_tone | 1.56725194 |
| 45 | MP0005409_darkened_coat_color | 1.52448432 |
| 46 | MP0004510_myositis | 1.51010725 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.49835415 |
| 48 | MP0002557_abnormal_social/conspecific_i | 1.49493858 |
| 49 | MP0002066_abnormal_motor_capabilities/c | 1.47750759 |
| 50 | MP0002882_abnormal_neuron_morphology | 1.44809705 |
| 51 | MP0002184_abnormal_innervation | 1.44764578 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.43783344 |
| 53 | MP0001984_abnormal_olfaction | 1.41397012 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.40168572 |
| 55 | MP0009780_abnormal_chondrocyte_physiolo | 1.39299268 |
| 56 | MP0005330_cardiomyopathy | 1.38130301 |
| 57 | MP0000751_myopathy | 1.37727350 |
| 58 | MP0004742_abnormal_vestibular_system | 1.36319121 |
| 59 | MP0003633_abnormal_nervous_system | 1.31869699 |
| 60 | MP0001485_abnormal_pinna_reflex | 1.30843467 |
| 61 | MP0002229_neurodegeneration | 1.30550621 |
| 62 | MP0002972_abnormal_cardiac_muscle | 1.29905000 |
| 63 | MP0003634_abnormal_glial_cell | 1.28911908 |
| 64 | MP0003631_nervous_system_phenotype | 1.22007392 |
| 65 | MP0005451_abnormal_body_composition | 1.20567110 |
| 66 | MP0006036_abnormal_mitochondrial_physio | 1.17420822 |
| 67 | MP0003879_abnormal_hair_cell | 1.16731152 |
| 68 | MP0006276_abnormal_autonomic_nervous | 1.15577406 |
| 69 | MP0002638_abnormal_pupillary_reflex | 1.14932400 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.14649035 |
| 71 | MP0003632_abnormal_nervous_system | 1.10045548 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.06589779 |
| 73 | MP0008874_decreased_physiological_sensi | 1.06094918 |
| 74 | MP0002108_abnormal_muscle_morphology | 1.05976110 |
| 75 | MP0000733_abnormal_muscle_development | 1.04930569 |
| 76 | MP0001188_hyperpigmentation | 1.04878019 |
| 77 | MP0002152_abnormal_brain_morphology | 1.01150570 |
| 78 | MP0004858_abnormal_nervous_system | 1.00123229 |
| 79 | MP0001177_atelectasis | 0.99711478 |
| 80 | MP0005551_abnormal_eye_electrophysiolog | 0.99311415 |
| 81 | MP0004085_abnormal_heartbeat | 0.95853457 |
| 82 | MP0000747_muscle_weakness | 0.92321867 |
| 83 | MP0005171_absent_coat_pigmentation | 0.92124356 |
| 84 | MP0003075_altered_response_to | 0.88559818 |
| 85 | MP0003137_abnormal_impulse_conducting | 0.88122773 |
| 86 | MP0001963_abnormal_hearing_physiology | 0.86881686 |
| 87 | MP0002069_abnormal_eating/drinking_beha | 0.85382847 |
| 88 | MP0002752_abnormal_somatic_nervous | 0.85367282 |
| 89 | MP0003045_fibrosis | 0.84555712 |
| 90 | MP0003787_abnormal_imprinting | 0.83891378 |
| 91 | MP0002971_abnormal_brown_adipose | 0.83611777 |
| 92 | MP0000604_amyloidosis | 0.83338781 |
| 93 | MP0008872_abnormal_physiological_respon | 0.82805113 |
| 94 | MP0002837_dystrophic_cardiac_calcinosis | 0.82486858 |
| 95 | MP0003123_paternal_imprinting | 0.80792779 |
| 96 | MP0005266_abnormal_metabolism | 0.77911434 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.77289974 |
| 98 | MP0005535_abnormal_body_temperature | 0.76377200 |
| 99 | MP0005167_abnormal_blood-brain_barrier | 0.75299547 |
| 100 | MP0002090_abnormal_vision | 0.74417290 |
| 101 | MP0004043_abnormal_pH_regulation | 0.72736710 |
| 102 | MP0010630_abnormal_cardiac_muscle | 0.71943121 |
| 103 | MP0000003_abnormal_adipose_tissue | 0.71835753 |
| 104 | MP0001544_abnormal_cardiovascular_syste | 0.71385335 |
| 105 | MP0005385_cardiovascular_system_phenoty | 0.71385335 |
| 106 | MP0004036_abnormal_muscle_relaxation | 0.70485811 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.69292529 |
| 108 | MP0006138_congestive_heart_failure | 0.69098014 |
| 109 | MP0004215_abnormal_myocardial_fiber | 0.68731266 |
| 110 | MP0002127_abnormal_cardiovascular_syste | 0.66203707 |
| 111 | MP0002876_abnormal_thyroid_physiology | 0.66087973 |
| 112 | MP0005623_abnormal_meninges_morphology | 0.65185463 |
| 113 | MP0000631_abnormal_neuroendocrine_gland | 0.64662145 |
| 114 | MP0005410_abnormal_fertilization | 0.59207167 |
| 115 | MP0000749_muscle_degeneration | 0.58747823 |
| 116 | MP0001664_abnormal_digestion | 0.58711800 |
| 117 | MP0005620_abnormal_muscle_contractility | 0.57895868 |
| 118 | MP0003283_abnormal_digestive_organ | 0.56753980 |
| 119 | MP0001943_abnormal_respiration | 0.53701513 |
| 120 | MP0003122_maternal_imprinting | 0.52578196 |
| 121 | MP0004147_increased_porphyrin_level | 0.51806751 |
| 122 | MP0004130_abnormal_muscle_cell | 0.49376456 |
| 123 | MP0004484_altered_response_of | 0.49072133 |
| 124 | MP0010769_abnormal_survival | 0.48121155 |
| 125 | MP0000026_abnormal_inner_ear | 0.47889490 |
| 126 | MP0003646_muscle_fatigue | 0.47384755 |
| 127 | MP0003956_abnormal_body_size | 0.45074977 |
| 128 | MP0010770_preweaning_lethality | 0.44960715 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 8.88873064 |
| 2 | Nemaline bodies (HP:0003798) | 8.76440530 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 8.59520354 |
| 4 | Myokymia (HP:0002411) | 7.46092199 |
| 5 | Focal motor seizures (HP:0011153) | 6.85303821 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 6.48896157 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 6.14794954 |
| 8 | Focal seizures (HP:0007359) | 5.05943467 |
| 9 | Myopathic facies (HP:0002058) | 4.74666918 |
| 10 | Calf muscle hypertrophy (HP:0008981) | 4.61291738 |
| 11 | Distal arthrogryposis (HP:0005684) | 4.59704064 |
| 12 | EMG: myopathic abnormalities (HP:0003458) | 4.59196873 |
| 13 | Atonic seizures (HP:0010819) | 4.53725872 |
| 14 | Hyporeflexia of lower limbs (HP:0002600) | 4.19110098 |
| 15 | Muscle fiber splitting (HP:0003555) | 4.11091058 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 4.03218028 |
| 17 | Myoglobinuria (HP:0002913) | 4.00050779 |
| 18 | Epileptic encephalopathy (HP:0200134) | 3.98980323 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.91827863 |
| 20 | Difficulty running (HP:0009046) | 3.87014299 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 3.85796411 |
| 22 | Action tremor (HP:0002345) | 3.81807152 |
| 23 | Rhabdomyolysis (HP:0003201) | 3.80268331 |
| 24 | Dysmetria (HP:0001310) | 3.77557690 |
| 25 | Visual hallucinations (HP:0002367) | 3.75182881 |
| 26 | Ankle clonus (HP:0011448) | 3.68592732 |
| 27 | Round ear (HP:0100830) | 3.67157726 |
| 28 | Spastic gait (HP:0002064) | 3.61051437 |
| 29 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.58153719 |
| 30 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.57208647 |
| 31 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.57208647 |
| 32 | Rimmed vacuoles (HP:0003805) | 3.45621219 |
| 33 | Myotonia (HP:0002486) | 3.42984532 |
| 34 | Absence seizures (HP:0002121) | 3.41144670 |
| 35 | Sudden death (HP:0001699) | 3.40633016 |
| 36 | Bundle branch block (HP:0011710) | 3.40188223 |
| 37 | Progressive cerebellar ataxia (HP:0002073) | 3.39868629 |
| 38 | Febrile seizures (HP:0002373) | 3.39214948 |
| 39 | Neck muscle weakness (HP:0000467) | 3.38023307 |
| 40 | Broad-based gait (HP:0002136) | 3.35995952 |
| 41 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.35903133 |
| 42 | Subaortic stenosis (HP:0001682) | 3.35903133 |
| 43 | Gaze-evoked nystagmus (HP:0000640) | 3.34798425 |
| 44 | Intention tremor (HP:0002080) | 3.33430979 |
| 45 | Abnormality of the corticospinal tract (HP:0002492) | 3.31675129 |
| 46 | Frequent falls (HP:0002359) | 3.30748757 |
| 47 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.30505205 |
| 48 | Dialeptic seizures (HP:0011146) | 3.29431830 |
| 49 | Generalized tonic-clonic seizures (HP:0002069) | 3.26942071 |
| 50 | Sensory axonal neuropathy (HP:0003390) | 3.23287544 |
| 51 | Muscle stiffness (HP:0003552) | 3.22130668 |
| 52 | Cerebral inclusion bodies (HP:0100314) | 3.21088450 |
| 53 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.18652712 |
| 54 | Dysdiadochokinesis (HP:0002075) | 3.17587227 |
| 55 | Scanning speech (HP:0002168) | 3.17585552 |
| 56 | Ulnar deviation of the wrist (HP:0003049) | 3.10304454 |
| 57 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.07726541 |
| 58 | Anxiety (HP:0000739) | 3.04364134 |
| 59 | Poor eye contact (HP:0000817) | 2.93660065 |
| 60 | Torticollis (HP:0000473) | 2.92860722 |
| 61 | Increased variability in muscle fiber diameter (HP:0003557) | 2.90002673 |
| 62 | Postural instability (HP:0002172) | 2.83735327 |
| 63 | Depression (HP:0000716) | 2.83033077 |
| 64 | EMG: neuropathic changes (HP:0003445) | 2.81161393 |
| 65 | Peripheral hypomyelination (HP:0007182) | 2.79152941 |
| 66 | Increased connective tissue (HP:0009025) | 2.77725474 |
| 67 | Abnormal social behavior (HP:0012433) | 2.73577159 |
| 68 | Impaired social interactions (HP:0000735) | 2.73577159 |
| 69 | Urinary urgency (HP:0000012) | 2.72117856 |
| 70 | Malignant hyperthermia (HP:0002047) | 2.69939485 |
| 71 | Hyperventilation (HP:0002883) | 2.68276469 |
| 72 | Akinesia (HP:0002304) | 2.64893840 |
| 73 | Calcaneovalgus deformity (HP:0001848) | 2.63248330 |
| 74 | Abnormal eating behavior (HP:0100738) | 2.61753177 |
| 75 | Lower limb muscle weakness (HP:0007340) | 2.59922209 |
| 76 | Fetal akinesia sequence (HP:0001989) | 2.59633963 |
| 77 | Distal lower limb muscle weakness (HP:0009053) | 2.58943058 |
| 78 | Megalencephaly (HP:0001355) | 2.56618681 |
| 79 | Absent phalangeal crease (HP:0006109) | 2.55754746 |
| 80 | Onion bulb formation (HP:0003383) | 2.54244809 |
| 81 | Focal dystonia (HP:0004373) | 2.53103159 |
| 82 | Insidious onset (HP:0003587) | 2.52763131 |
| 83 | Termporal pattern (HP:0011008) | 2.52763131 |
| 84 | Hyperkalemia (HP:0002153) | 2.50329456 |
| 85 | Truncal ataxia (HP:0002078) | 2.49922949 |
| 86 | Areflexia of lower limbs (HP:0002522) | 2.49510446 |
| 87 | Pheochromocytoma (HP:0002666) | 2.47608196 |
| 88 | Craniofacial dystonia (HP:0012179) | 2.39875435 |
| 89 | Generalized muscle weakness (HP:0003324) | 2.38686192 |
| 90 | Progressive inability to walk (HP:0002505) | 2.38379202 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.35541008 |
| 92 | Generalized myoclonic seizures (HP:0002123) | 2.32942119 |
| 93 | Exercise-induced myalgia (HP:0003738) | 2.32193114 |
| 94 | Deformed tarsal bones (HP:0008119) | 2.28604398 |
| 95 | Amblyopia (HP:0000646) | 2.28430055 |
| 96 | Asymmetric septal hypertrophy (HP:0001670) | 2.27591115 |
| 97 | Heart block (HP:0012722) | 2.26374356 |
| 98 | Clonus (HP:0002169) | 2.24981898 |
| 99 | Stereotypic behavior (HP:0000733) | 2.23118425 |
| 100 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.22785737 |
| 101 | Fatigable weakness (HP:0003473) | 2.18000854 |
| 102 | Abnormality of the neuromuscular junction (HP:0003398) | 2.18000854 |
| 103 | Bulbar palsy (HP:0001283) | 2.17074159 |
| 104 | Prolonged QT interval (HP:0001657) | 2.15782545 |
| 105 | Limb dystonia (HP:0002451) | 2.14862111 |
| 106 | Annular pancreas (HP:0001734) | 2.14331242 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 2.13919918 |
| 108 | Gowers sign (HP:0003391) | 2.13359898 |
| 109 | Abnormality of the foot musculature (HP:0001436) | 2.13177898 |
| 110 | Thickened helices (HP:0000391) | 2.10541953 |
| 111 | Impaired vibratory sensation (HP:0002495) | 2.10434012 |
| 112 | Weak cry (HP:0001612) | 2.09178835 |
| 113 | Mutism (HP:0002300) | 2.08518023 |
| 114 | Abnormality of saccadic eye movements (HP:0000570) | 2.07203196 |
| 115 | Abnormal atrioventricular conduction (HP:0005150) | 2.06880851 |
| 116 | Bowel incontinence (HP:0002607) | 2.06811063 |
| 117 | Abnormal finger flexion creases (HP:0006143) | 2.06519339 |
| 118 | Foot dorsiflexor weakness (HP:0009027) | 2.06147663 |
| 119 | Resting tremor (HP:0002322) | 2.05328221 |
| 120 | Aplasia involving bones of the extremities (HP:0009825) | 2.04638638 |
| 121 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.04638638 |
| 122 | Aplasia of the phalanges of the hand (HP:0009802) | 2.04638638 |
| 123 | Nonprogressive disorder (HP:0003680) | 2.03877417 |
| 124 | Ventricular fibrillation (HP:0001663) | 2.02937639 |
| 125 | Slow saccadic eye movements (HP:0000514) | 2.02832136 |
| 126 | Hemiparesis (HP:0001269) | 2.02566168 |
| 127 | Difficulty climbing stairs (HP:0003551) | 2.00531139 |
| 128 | Absent speech (HP:0001344) | 1.99611040 |
| 129 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.98480318 |
| 130 | Bradykinesia (HP:0002067) | 1.98243750 |
| 131 | Genetic anticipation (HP:0003743) | 1.95051859 |
| 132 | Increased circulating renin level (HP:0000848) | 1.94162209 |
| 133 | Incomplete penetrance (HP:0003829) | 1.93834367 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.93820560 |
| 135 | Abnormal EKG (HP:0003115) | 1.93787968 |
| 136 | Drooling (HP:0002307) | 1.92983723 |
| 137 | Excessive salivation (HP:0003781) | 1.92983723 |
| 138 | Cerebral hypomyelination (HP:0006808) | 1.92640126 |
| 139 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.91070700 |
| 140 | Scapular winging (HP:0003691) | 1.90746732 |
| 141 | Lower limb amyotrophy (HP:0007210) | 1.90636284 |
| 142 | Slender build (HP:0001533) | 1.89555596 |
| 143 | Abnormal large intestine physiology (HP:0012700) | 1.89465870 |
| 144 | Retinal dysplasia (HP:0007973) | 1.89268195 |
| 145 | Rigidity (HP:0002063) | 1.88842671 |
| 146 | Dysmetric saccades (HP:0000641) | 1.87614842 |
| 147 | Epileptiform EEG discharges (HP:0011182) | 1.86667826 |
| 148 | Dilated cardiomyopathy (HP:0001644) | 1.84656919 |
| 149 | Papilledema (HP:0001085) | 1.84442308 |
| 150 | Abnormality of binocular vision (HP:0011514) | 1.84302876 |
| 151 | Diplopia (HP:0000651) | 1.84302876 |
| 152 | Hammertoe (HP:0001765) | 1.80781063 |
| 153 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79359817 |
| 154 | Psychosis (HP:0000709) | 1.78676576 |
| 155 | Impaired smooth pursuit (HP:0007772) | 1.77939809 |
| 156 | Alacrima (HP:0000522) | 1.77705610 |
| 157 | Ventricular arrhythmia (HP:0004308) | 1.77237306 |
| 158 | Limb-girdle muscle atrophy (HP:0003797) | 1.77140916 |
| 159 | Blue irides (HP:0000635) | 1.76482070 |
| 160 | Tetraplegia (HP:0002445) | 1.71887192 |
| 161 | Obstructive sleep apnea (HP:0002870) | 1.71522298 |
| 162 | Syncope (HP:0001279) | 1.71481817 |
| 163 | Proximal amyotrophy (HP:0007126) | 1.70523309 |
| 164 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.69876461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 7.26419890 |
| 2 | EPHA4 | 5.49677718 |
| 3 | NTRK3 | 3.69371451 |
| 4 | TTN | 3.22410139 |
| 5 | MAP3K9 | 3.04041319 |
| 6 | TNIK | 2.89291304 |
| 7 | PRPF4B | 2.84843485 |
| 8 | STK39 | 2.51879236 |
| 9 | OXSR1 | 2.33178887 |
| 10 | PAK6 | 2.23350558 |
| 11 | KSR2 | 2.12430623 |
| 12 | MAP3K4 | 2.09522918 |
| 13 | CDK19 | 2.06295228 |
| 14 | NTRK1 | 2.02789485 |
| 15 | DAPK2 | 1.98718538 |
| 16 | MINK1 | 1.91560001 |
| 17 | MARK1 | 1.87140979 |
| 18 | MAPK12 | 1.84088683 |
| 19 | ARAF | 1.75982692 |
| 20 | NTRK2 | 1.69487462 |
| 21 | PRKD3 | 1.63949581 |
| 22 | MAP3K13 | 1.59935570 |
| 23 | MAP2K7 | 1.57629037 |
| 24 | TYRO3 | 1.55123321 |
| 25 | CDK5 | 1.54262864 |
| 26 | RIPK4 | 1.50135050 |
| 27 | FES | 1.45057643 |
| 28 | UHMK1 | 1.39353869 |
| 29 | CAMKK1 | 1.38056935 |
| 30 | NEK6 | 1.32640924 |
| 31 | PNCK | 1.31976456 |
| 32 | WNK1 | 1.28069917 |
| 33 | MAP2K4 | 1.26378498 |
| 34 | KSR1 | 1.25559808 |
| 35 | ICK | 1.21561214 |
| 36 | CASK | 1.21218210 |
| 37 | LATS2 | 1.20187260 |
| 38 | PHKG1 | 1.19709997 |
| 39 | PHKG2 | 1.19709997 |
| 40 | PIK3CG | 1.16345493 |
| 41 | CAMK2B | 1.15944388 |
| 42 | BCR | 1.12409235 |
| 43 | SGK223 | 1.08799211 |
| 44 | SGK494 | 1.08799211 |
| 45 | WNK4 | 1.08046566 |
| 46 | PINK1 | 1.04979667 |
| 47 | MAP3K2 | 1.04675585 |
| 48 | CAMK2A | 1.02108736 |
| 49 | MARK2 | 0.98575190 |
| 50 | MAPK13 | 0.96458699 |
| 51 | CAMK4 | 0.96169174 |
| 52 | CDK14 | 0.96039315 |
| 53 | CDK15 | 0.95690267 |
| 54 | RIPK1 | 0.95324315 |
| 55 | CDK18 | 0.94083617 |
| 56 | PKN1 | 0.92150185 |
| 57 | PRKCG | 0.90969841 |
| 58 | STK11 | 0.90361076 |
| 59 | MAP2K6 | 0.89444235 |
| 60 | PRKCH | 0.89208141 |
| 61 | CAMK2D | 0.88934832 |
| 62 | GRK5 | 0.88034291 |
| 63 | BMPR2 | 0.87963857 |
| 64 | CSNK1G2 | 0.87064790 |
| 65 | CAMKK2 | 0.86534120 |
| 66 | STK38 | 0.85003501 |
| 67 | TAOK1 | 0.84756658 |
| 68 | CDK11A | 0.84647576 |
| 69 | RAF1 | 0.82787076 |
| 70 | FGFR2 | 0.82671253 |
| 71 | PDPK1 | 0.81214604 |
| 72 | ROCK2 | 0.80570328 |
| 73 | PAK3 | 0.78389572 |
| 74 | DAPK1 | 0.77663513 |
| 75 | FGR | 0.77366998 |
| 76 | PLK2 | 0.76695173 |
| 77 | CAMK2G | 0.76628367 |
| 78 | MAP3K12 | 0.76582688 |
| 79 | CAMK1 | 0.74084988 |
| 80 | PTK2B | 0.73415485 |
| 81 | SGK1 | 0.66645016 |
| 82 | TNK2 | 0.66287077 |
| 83 | PRKG1 | 0.65010919 |
| 84 | PDK1 | 0.64915011 |
| 85 | PRKAA1 | 0.64667544 |
| 86 | SIK2 | 0.64131639 |
| 87 | CSNK1G3 | 0.61910339 |
| 88 | NME1 | 0.61082765 |
| 89 | FYN | 0.61078951 |
| 90 | CCNB1 | 0.59404119 |
| 91 | MAPKAPK3 | 0.55828293 |
| 92 | RET | 0.55029014 |
| 93 | LMTK2 | 0.53931990 |
| 94 | CSNK1A1L | 0.53778473 |
| 95 | PRKCE | 0.51332089 |
| 96 | MAP3K1 | 0.50749908 |
| 97 | ALK | 0.50507371 |
| 98 | EPHB1 | 0.50500422 |
| 99 | SGK2 | 0.48435730 |
| 100 | MUSK | 0.47363735 |
| 101 | PRKAA2 | 0.47349394 |
| 102 | ROCK1 | 0.47104073 |
| 103 | SGK3 | 0.46986490 |
| 104 | PRKCQ | 0.46795076 |
| 105 | RPS6KA3 | 0.46186332 |
| 106 | MAPK10 | 0.45683667 |
| 107 | INSRR | 0.44960550 |
| 108 | MAPK4 | 0.44923571 |
| 109 | MAPKAPK5 | 0.43901286 |
| 110 | LIMK1 | 0.43871051 |
| 111 | MAP2K1 | 0.43815331 |
| 112 | PRKACA | 0.43764460 |
| 113 | DYRK1A | 0.43462884 |
| 114 | TRPM7 | 0.41800113 |
| 115 | CAMK1G | 0.41573015 |
| 116 | DYRK1B | 0.41138051 |
| 117 | MAPK7 | 0.40886860 |
| 118 | DMPK | 0.40761462 |
| 119 | PRKD2 | 0.40710663 |
| 120 | AKT2 | 0.40669532 |
| 121 | MAP2K3 | 0.40041161 |
| 122 | DAPK3 | 0.39881424 |
| 123 | MOS | 0.39272405 |
| 124 | PRKCZ | 0.37741486 |
| 125 | MAP3K7 | 0.36842378 |
| 126 | MAP3K11 | 0.33237957 |
| 127 | ERBB3 | 0.28909197 |
| 128 | RPS6KB1 | 0.28145089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.19298599 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.90866338 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.89282238 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.69808183 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.65914048 |
| 6 | Morphine addiction_Homo sapiens_hsa05032 | 2.61592654 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.60915210 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.54098349 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.42544852 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.38194981 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15488813 |
| 12 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.12029565 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.06517623 |
| 14 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.97610338 |
| 15 | Cocaine addiction_Homo sapiens_hsa05030 | 1.94172501 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.81667848 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76281364 |
| 18 | Long-term depression_Homo sapiens_hsa04730 | 1.73688144 |
| 19 | Insulin secretion_Homo sapiens_hsa04911 | 1.68181683 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.66434267 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.65462746 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.64484109 |
| 23 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63663554 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.62327115 |
| 25 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.60870390 |
| 26 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59796922 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57506642 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.54350615 |
| 29 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.37028551 |
| 30 | * Axon guidance_Homo sapiens_hsa04360 | 1.36648393 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35784703 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.33345260 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.32541601 |
| 34 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.32164791 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.28864163 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.26155173 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.25130980 |
| 38 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.21555893 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17403312 |
| 40 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.15943101 |
| 41 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.15727939 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15153847 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13443294 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.11325556 |
| 45 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.09410065 |
| 46 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08722845 |
| 47 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.05600513 |
| 48 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.02513875 |
| 49 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97666516 |
| 50 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.92122461 |
| 51 | Phototransduction_Homo sapiens_hsa04744 | 0.91924711 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.91903950 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.91349977 |
| 54 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88402489 |
| 55 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.87519247 |
| 56 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.86896877 |
| 57 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.86760747 |
| 58 | Melanogenesis_Homo sapiens_hsa04916 | 0.86252490 |
| 59 | Glioma_Homo sapiens_hsa05214 | 0.82746731 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79831390 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.79620181 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.79425682 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77244403 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77093658 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77048010 |
| 66 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.76726714 |
| 67 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75817333 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74645814 |
| 69 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.74381420 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.71941696 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71159029 |
| 72 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.70880948 |
| 73 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.69155448 |
| 74 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.66315018 |
| 75 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.65897626 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.65074242 |
| 77 | Carbon metabolism_Homo sapiens_hsa01200 | 0.64925063 |
| 78 | Endocytosis_Homo sapiens_hsa04144 | 0.64729701 |
| 79 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.64616662 |
| 80 | Parkinsons disease_Homo sapiens_hsa05012 | 0.64207221 |
| 81 | Insulin resistance_Homo sapiens_hsa04931 | 0.61847238 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59869873 |
| 83 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59228052 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58072006 |
| 85 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.57173819 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56319042 |
| 87 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56094603 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.55864212 |
| 89 | Alcoholism_Homo sapiens_hsa05034 | 0.54715295 |
| 90 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.54569912 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51999339 |
| 92 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51193854 |
| 93 | Tight junction_Homo sapiens_hsa04530 | 0.50428477 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.47365410 |
| 95 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47265497 |
| 96 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47250142 |
| 97 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47121312 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46574222 |
| 99 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.45337938 |
| 100 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.45116707 |
| 101 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44959028 |
| 102 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42813141 |
| 103 | Bile secretion_Homo sapiens_hsa04976 | 0.41834369 |
| 104 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41285803 |
| 105 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.41065853 |
| 106 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40404391 |
| 107 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.39770626 |
| 108 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.39537309 |
| 109 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39329121 |
| 110 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.38147675 |
| 111 | Circadian rhythm_Homo sapiens_hsa04710 | 0.37968924 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36912077 |
| 113 | Prion diseases_Homo sapiens_hsa05020 | 0.36550021 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.35600193 |
| 115 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35467028 |
| 116 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.35005427 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.34872019 |
| 118 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34714214 |
| 119 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34308142 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.34216924 |
| 121 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31710388 |
| 122 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.31538215 |
| 123 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.30785873 |
| 124 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30683257 |
| 125 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.29658007 |
| 126 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29651712 |

